Blog

As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from the official campaign suggestion of recreating the Rare Disease Day logo, our staff enthusiastically joined in to produce two canvases made from hundreds of individual handprints. The final recreation of the logo on one of […]

Developing new drugs is a rigorous and detailed process, requiring close scrutiny and testing across clinical trials in order for the drug to successfully find its way to market. The development process is necessary for understanding drug safety and efficacy before it becomes available for public use. And with patients at the heart of clinical […]

Clinical research helps develop new evidence-based approaches to treating health conditions, resulting in better, safer and more effective treatments. However, in the case of studying rare disease treatments, clinical research can be particularly challenging. This can be for a number of reasons, such as the rare disease not being fully understood, a lack of awareness […]

Clinical trials involve a series of studies that test the safety and effectiveness of drugs and other medical treatments. To ensure research is carried out thoroughly and safely, there are several different stages of clinical trials.  In order to make sure the treatment is safe and effective for use in patients, it must successfully pass […]